Video

Balancing Cost and Care in Specialty Pharmacy

Author(s):

Lauren Santye, Assistant Editor

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses challenges balancing the quality of care with the high cost of treatments.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses challenges balancing the quality of care with the high cost of treatments.

Related Videos
Pharmacist and a patient -- Image credit: Zamrznuti tonovi | stock.adobe.com
October is American Pharmacists Month.
American Pharmacist Month | Image Credit: Zoran Zeremski - stock.adobe.com
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Patient receiving cancer care from provider -- Image credit: Rido | stock.adobe.com
Patient taking prescription medicine -- Image credit: Rawpixel.com | stock.adobe.com
Artificial intelligence in health care -- Image credit: Martinesku | stock.adobe.com
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy School, social media, non-traditional learning | Image Credit: Ахтем - stock.adobe.com
Children's doctor vaccinating little boy at home.
Related Content
In this photo illustration, the Centers for Medicare and Medicaid Services (CMS) logo is displayed on a smartphone screen.
October 8th 2024

What Drug Rates Are Reported in Price Transparency Data?

Chris O'Dell
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Eye of the Beholder: Understanding The Subjective Experience of Acute Ketamine Treatment
October 4th 2024

Eye of the Beholder: Understanding The Subjective Experience of Acute Ketamine Treatment

Jack Vinciguerra, PharmD
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Danon Disease, FDA, Orphan Drug Designation | Image Credit: C Davids/peopleimages.com - stock.adobe.com
October 3rd 2024

FDA Grants Orphan Drug Designation to PPL-002 for the Treatment of Danon Disease

Ashley Gallagher, Associate Editor
Biosimilar Eye Care | Image Credit: Mahachoke 4289-6395 - stock.adobe.com
October 2nd 2024

Data Supports Approval of Biosimilar Aflibercept for Diabetic Macular Edema

Ashley Gallagher, Associate Editor